SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-055385
Filing Date
2009-03-16
Accepted
2009-03-16 16:04:35
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1586071
2 1999 EQUITY INCENTIVE PLAN, AS AMENDED dex101.htm EX-10.1 29352
3 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2156
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9621
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9592
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 5563
7 GRAPHIC g63228g33s77.jpg GRAPHIC 55858
  Complete submission text file 0001193125-09-055385.txt   1720879
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 09684359
SIC: 2836 Biological Products, (No Diagnostic Substances)